IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

Item
http://www.wikidata.org/entity/Q35147651
Neural stem/progenitor cells in Alzheimer's diseaseThe involvement of BDNF, NGF and GDNF in aging and Alzheimer's diseaseIntranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.The effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formationInsulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic miceInsulin Like Growth Factor 2 Expression in the Rat Brain Both in Basal Condition and following Learning Predominantly Derives from the Maternal Allele.Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model MiceNetrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.Intrinsic Cholinergic Neurons in the Hippocampus: Fact or Artifact?Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition.Peptides derived from the knuckle epitope of BMP-9 induce the cholinergic differentiation and inactivate GSk3beta in human SH-SY5Y neuroblastoma cells.Neuroprotective Actions of Dietary Choline.Insulin-like growth factor 2 rescues aging-related memory loss in rats.Neuroprotection by aripiprazole against β-amyloid-induced toxicity by P-CK2α activation via inhibition of GSK-3β.The behavioral deficits and cognitive impairment are correlated with decreased IGF-II and ERK in depressed mice induced by chronic unpredictable stress.Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
P2860

IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

Item
http://www.wikidata.org/entity/Q35147651
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@ast
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@en
type
label
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@ast
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@en
prefLabel
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@ast
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
IGF2 ameliorates amyloidosis, ...... lzheimer's disease model mice.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0094287
P407
P433
P478
P50
P577
P5875
P698
P921
P932